Boston Strategic Partners, Inc. is utilizing its extensive experience with Health Economics and Outcomes Research (HEOR) and ‘big data’ to provide in-depth analysis of hospital treated sepsis.

In 2014, US healthcare spending exceeded $3.0 trillion with nearly 1/3 spent on hospitalizations. BSP’s real-world data report, Hospital Treated Sepsis, estimates 30% of all hospital discharges involve treatment of infectious organisms. Sepsis is responsible for an estimated 12% of all hospital stays. At an average cost of $15,500 per occurrence, we estimate that hospitalizations for severe infections account for $212 billion in annual spending or 7% of total healthcare expenditure. In this report, we conduct an in-depth analysis of sepsis patient characteristics, medication management, costs, and laboratory testing.

Gram-positive bacteria are the likely causative agents of most sepsis infections. Physicians treat the vast majority of these infections with vancomycin, piperacillin-tazobactam, levofloxacin, and ceftriaxone. From 2010-2015, drug-resistant organisms caused an astonishing 40% of bacterial sepsis infections. After confirmatory diagnosis, over half of sepsis patients undergo a change in antibiotic therapy.

This report provides quantitative, objective data using real-world patient encounters and reflects real physician decisions and encounter characteristics (e.g. patient response to therapy and outcomes) in key areas, such as antibiotic resistant pathogens and antimicrobial stewardship.

Hospital-Treated Sepsis Report is available at www.bostonsp.com/reports

Some of our recent reports include:

  • Hospital-Treated Pneumonia – Diagnosis
  • Hospital-Treated Pneumonia – Treatment

Reports in development: 

  • Acute Myocardial Infarction
  • Antibiotic resistance
  • Chronic Kidney Disease (CKD)
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Extrinsic Asthma
  • Hip and knee surgery
  • Hypertension
  • Influenza (and resulting complications)
  • Obesity
  • Osteoarthritis
  • Schizophrenia
  • Stroke
  • Type 2 Diabetes (and resulting complications)

Custom reports are also available. If you have interest in these reports or any others please contact us directly at realworldreports@bostonsp.com for more information.

About BSP
Founded in 2003, Boston Strategic Partners, Inc. is a dedicated healthcare and life sciences company. We offer five different types of services:

For more information or to schedule a meeting with our team, please email us at info@bostonsp.com